scholarly article | Q13442814 |
P2093 | author name string | Paul Grant | |
Shamin Ramasamy | |||
P2860 | cites work | Polycystic ovary syndrome (PCOS) and other androgen excess-related conditions: can changes in dietary intake make a difference? | Q37060111 |
Serenoa repens extract in the treatment of benign prostatic hyperplasia | Q37942163 | ||
Cycloartane triterpenoids from Cimicifuga yunnanensis induce apoptosis of breast cancer cells (MCF7) via p53-dependent mitochondrial signaling pathway. | Q39690319 | ||
Apoptosis of human prostate androgen-dependent and -independent carcinoma cells induced by an isopropanolic extract of black cohosh involves degradation of cytokeratin (CK) 18. | Q40437732 | ||
Anti-androgenic activities of Ganoderma lucidum | Q46609011 | ||
Think androgen deficiency. | Q50602537 | ||
Complementary and alternative medicine therapies in acne, psoriasis, and atopic eczema: results of a qualitative study of patients' experiences and perceptions. | Q54724977 | ||
Reduction of serum testosterone in men by licorice | Q73069960 | ||
Serenoa repens for benign prostatic hyperplasia | Q24241144 | ||
Serenoa Repens: Does It have Any Role in the Management of Androgenetic Alopecia? | Q24622952 | ||
Serenoa repens for benign prostatic hyperplasia | Q28215754 | ||
Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia | Q28277055 | ||
Saw palmetto for benign prostatic hyperplasia | Q28296308 | ||
American palm ethnomedicine: a meta-analysis | Q33582856 | ||
Vitex agnus castus: a systematic review of adverse events | Q33985924 | ||
Estrogen-like activity of glabrene and other constituents isolated from licorice root | Q34094641 | ||
Opioidergic mechanisms underlying the actions of Vitex agnus-castus L. | Q34138927 | ||
Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia | Q34309375 | ||
Estrogen-like activity of licorice root constituents: glabridin and glabrene, in vascular tissues in vitro and in vivo | Q34336109 | ||
The effects of a special Agnus castus extract (BP1095E1) on prolactin secretion in healthy male subjects | Q34415509 | ||
Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial | Q34573472 | ||
Effect of spearmint (Mentha spicata Labiatae) teas on androgen levels in women with hirsutism | Q34575913 | ||
Effect of paeoniflorin, glycyrrhizin and glycyrrhetic acid on ovarian androgen production | Q34869899 | ||
Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. A randomized controlled trial | Q34991202 | ||
Male hormonal contraception: an update on research progress | Q36084158 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 497-502 | |
P577 | publication date | 2012-01-01 | |
P1433 | published in | International journal of endocrinology and metabolism | Q26842330 |
P1476 | title | An update on plant derived anti-androgens | |
P478 | volume | 10 |
Q47549627 | Apoptosis: A Target for Anticancer Therapy |
Q38883820 | Bioactive natural products for chemoprevention and treatment of castration-resistant prostate cancer |
Q39209037 | Chinese Herbal Medicine for the Optimal Management of Polycystic Ovary Syndrome |
Q35745769 | Complementary Therapies for Idiopathic Hirsutism: Topical Licorice as Promising Option. |
Q36793123 | Green tea consumption is associated with reduced incident CHD and improved CHD-related biomarkers in the Dongfeng-Tongji cohort |
Q27002469 | Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings |
Q38934561 | Paeoniflorin, a novel heat-shock protein inducing compound, and human myometrial contractility in vitro |
Q92257071 | Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope |